Watch the recording below!
Meet the Panelists:
Lindsay E. Borden, MD - Gynecologic Oncologist
Lindsay Borden, M.D., is a fellowship-trained gynecologic oncology surgeon, board certified in obstetrics and gynecology. Dr. Borden specializes in treating gynecologic cancers with robotic and minimally invasive surgical techniques. Her experience includes treating endometrial, ovarian, cervical and vulvar cancers. Dr. Borden values a collaborative approach, working closely with various care team members to provide the best experience for her patients.
Dr. Borden earned her medical degree from the University of Virginia in Charlottesville and completed an OB-GYN residency at Virginia Tech Carilion School of Medicine in Roanoke. She completed a fellowship in gynecologic oncology at the University of Oklahoma Stephenson Cancer Center in Oklahoma City. She received recognition throughout her training for her excellence in patient care, teaching and research.
Virginia Oncology Associates
Sonia E. Hepburn, MD - Oncologist
Dr. Sonia Hepburn received her Bachelor of Science in Molecular Biology from Princeton University. She received her medical degree from the University of Southern California where she also did her internship/residency in Internal Medicine. She completed her Hematology/Oncology fellowship at the University of North Carolina - Chapel Hill.
During her fellowship, Dr. Hepburn was involved with Phase II and III clinical trials in Acute Myeloid Leukemia, where she published several abstracts and papers, co-wrote a book chapter, and conducted quality improvement projects to provide better outcomes for cancer patients.
She is an active member of the American Society of Clinical Oncology and the American Society of Hematology. She is trained in treating all cancer types with a special interest in breast, lung, and gastrointestinal cancers.
In her free time, Dr. Hepburn enjoys reading, running, cooking, and spending time with her family.
Sarah Pass, MMSc, CGC - Certified Genetic Counselor
Sarah is a Certified Genetic Counselor and Medical Science Liaison with Myriad Genetics. She received her Masters of Medical Science in Human Genetics and Genetic Counseling from Emory University. After graduation, she worked at as oncology clinical genetic counselor at MD Anderson Cancer Center and the Medical University of South Carolina before joining Myriad Genetics over 5 years ago. In her current role as Medical Science Liaison, she provides support and education to clinical providers surrounding hereditary cancer and somatic testing.
Iris Lundy, RN, BSN - Director of Health Equity
Iris Lundy, MHL, RN, BSN is the inaugural Vice President of Health Equity for Sentara Health, a large integrated delivery health system headquartered in Norfolk, Virginia. Through her experience as both a nurse and healthcare administrator she collaborates with leaders to develop and implement processes and practices which inform clinical performance, innovates community interventions, reduces barriers to care and improves health outcomes.
Her passion to promote health equity is immersed in her personal experiences within historically marginalized and rural communities, and her experience as an Army veteran. Ms. Lundy leads through a lens of cultural humility encouraging engagement and collaboration with diverse communities, civic and faith-based institutions to reduce disparities. She serves on multiple advisory boards and strategic alliances. Her compassionate leadership and ability to synthesize and translate information to a variety of communities has made her a sought-after speaker and trainer in organizational management and strategies to advance health equity.
Raphael Louie, MD - Surgical Oncology
Dr. Raphael Louie, a surgical oncologist at the Massey Cancer center of Richmond, recently completed an NIH T32 training grant in geriatric oncology at UNC where he was working with mentors in medical oncology, geriatrics, and public health to implement patient-reported outcome measures to improve perioperative risk assessment in geriatric surgical oncology population. His current research combines surgical oncology and public health interests to innovatively address disparities and to improve cancer care for the geriatric population.